NOTCH1 and hepatocellular carcinoma: First, inhibitors of EZH2 can target Notch1 through Notch1-related miRNAs, such as miR-21-5p, miR-26a-1-5p, and act on the corresponding HCC stem cells to reduce sorafenib resistance (37).